Latest News and Press Releases
Want to stay updated on the latest news?
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AVITA Medical, Inc. (“Avita”...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AVITA Medical, Inc. (“Avita” or...
-
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
Largest real-world RECELL study shows 6.2-day shorter hospital stays and $300 million in savings, presented at BBA 2025.
-
AVITA Medical announces the first clinical publication of Cohealyx, demonstrating significantly faster wound bed vascularization and autograft readiness.
-
Today: AVITA Medical’s Acute Wound Care Showcase 2025—clinical insights, patient stories, and transformative solutions in acute traumatic wound care.
-
AVITA Medical reported financial results for the first quarter 2025.
-
AVITA Medical to host Acute Wound Care Showcase 2025 via webcast on May 13, with leadership insights, product highlights, and clinical outcomes.
-
AVITA Medical will announce Q1 2025 financial results on May 8, 2025, followed by a conference call and webcast at 1:30 p.m. PT.
-
AVITA Medical announced that 16 abstracts will be presented at ABA 2025, featuring real-world and clinical data on RECELL, Cohealyx, and PermeaDerm.
-
AVITA Medical announces U.S. launch of Cohealyx™, a collagen-based dermal matrix designed to promote tissue integration and revascularization.